Racheal Githumbi,Steven J Katz,Jessica Widdifield,Claire E H Barber
{"title":"Update to a Systematic Review on Quality Measures for Rheumatoid Arthritis.","authors":"Racheal Githumbi,Steven J Katz,Jessica Widdifield,Claire E H Barber","doi":"10.3899/jrheum.2024-1314","DOIUrl":null,"url":null,"abstract":"OBJECTIVE\r\nThis work aims to provide an update on a previously published systematic review on quality measures (QMs) in rheumatoid arthritis (RA) to inform future measure development and endorsement efforts.\r\n\r\nMETHODS\r\nWe searched published and grey literature sources from January 2018-July 2023. Included sources were limited to those that targeted RA patients, either exclusively or alongside other rheumatic conditions and were guided by a clear consensus-building methodology. We extracted QMs and categorized them into topic and subtopics. Extracted measures were then reviewed for similarity with the previously extracted set from a published systematic review. Non-duplicative measures were labelled as \"new\".\r\n\r\nRESULTS\r\nThe updated search resulted in 2395 citations from which 339 studies were selected for full text review. From these, a total of six studies met the inclusion/exclusion criteria resulting in the extraction of 156 QMs, along with 31 additional QMs extracted from 87 grey literature sources. Amongst the 187 extracted QMs, most were duplicative and/or similar to previously developed measures (68%, n= 127). 60 were identified as \"new\". New QMs were primarily structural (50%, n= 30) and process measures (33%, n= 20). New QMs frequently addressed the topic of health care delivery (35%, n= 21).\r\n\r\nCONCLUSION\r\nWhile this review identified new QMs that reflect various reassuring trends in healthcare quality assessment, most were duplicative/similar to existing measures. This highlights the need for a centralized way to reduce redundancy in QM development efforts, and enable easy dissemination of QMs to optimize care for individuals with RA.","PeriodicalId":501812,"journal":{"name":"The Journal of Rheumatology","volume":"218 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2025-04-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"The Journal of Rheumatology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.3899/jrheum.2024-1314","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
OBJECTIVE
This work aims to provide an update on a previously published systematic review on quality measures (QMs) in rheumatoid arthritis (RA) to inform future measure development and endorsement efforts.
METHODS
We searched published and grey literature sources from January 2018-July 2023. Included sources were limited to those that targeted RA patients, either exclusively or alongside other rheumatic conditions and were guided by a clear consensus-building methodology. We extracted QMs and categorized them into topic and subtopics. Extracted measures were then reviewed for similarity with the previously extracted set from a published systematic review. Non-duplicative measures were labelled as "new".
RESULTS
The updated search resulted in 2395 citations from which 339 studies were selected for full text review. From these, a total of six studies met the inclusion/exclusion criteria resulting in the extraction of 156 QMs, along with 31 additional QMs extracted from 87 grey literature sources. Amongst the 187 extracted QMs, most were duplicative and/or similar to previously developed measures (68%, n= 127). 60 were identified as "new". New QMs were primarily structural (50%, n= 30) and process measures (33%, n= 20). New QMs frequently addressed the topic of health care delivery (35%, n= 21).
CONCLUSION
While this review identified new QMs that reflect various reassuring trends in healthcare quality assessment, most were duplicative/similar to existing measures. This highlights the need for a centralized way to reduce redundancy in QM development efforts, and enable easy dissemination of QMs to optimize care for individuals with RA.